Hansoh Pharmaceutical Group News and Activities
Presence
Hansoh Pharmaceutical Group develops, manufactures, and sells medicines in China. Its main products include oncology, central nervous system, anti-infective, and diabetes treatments for hospitals, doctors, and patients.
Hansoh Pharmaceutical Group products and services overview:
- Oncology medicines
- CNS medicines
- Anti infectives
- Diabetes treatments
- Autoimmune therapies
- Generic medicines
Revenue: ~$2 billion
Employees: 9,000
Headquarters: Shanghai, China
Hansoh Pharmaceutical Group is one of the...
Hansoh Pharmaceutical Group is a company listed under the stock ticker 3692 (HK).
Executives
View the org chart displaying its 11 main executives
Most searched biographies at Hansoh Pharmaceutical Group
- Huijuan Zhong, Executive Chairman of the Board and Chief Executive...
- Guoqiang Lin, Non-Executive Independent Director
- Dongtao Yang, Non-Executive Independent Director
Create your alert
to follow the executive moves at Hansoh Pharmaceutical Group.
Pharmaceuticals
Hansoh Pharmaceutical Group has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).
Popular M&A news in Pharmaceuticals
- Laboratoire Servier has announced the acquisition of Edgewise Therapeutics (posted on June 4 2026).
- Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
- Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
Popular contacts in Pharmaceuticals
News
Press releases by Hansoh Pharmaceutical Group
- 2022 ESMO丨翰森制药阿美替尼临床研究成果再传捷报_公司新闻_江苏豪森药业集团有限公司
- 2022 WCLC | 翰森制药阿美替尼21篇摘要闪耀登顶 原研之光展现中国创新力量_公司新闻_江苏豪森药业集团有限公司
Social media about Hansoh Pharmaceutical Group
- Hansoh Pharmaceutical Group on Wikipedia, Google News & Yahoo Finance
- Hansoh Pharmaceutical Group on LinkedIn, X (Twitter) & YouTube
